innat
immun
respons
provid
first
line
defens
viral
pathogen
innat
immun
activ
occur
antigenindepend
fashion
reli
abil
host
recogn
pathogen
specif
pattern
recognit
receptor
eg
tolllik
receptor
rigilik
receptor
nodlik
receptor
see
articl
issu
engag
molecul
activ
signal
pathway
lead
product
cytokin
chemokin
interferon
ifn
latter
bind
cognat
receptor
signal
jakstat
pathway
transcript
induc
hundr
interferonstimul
gene
isg
figur
type
ifnab
type
iii
ifn
often
consid
antivir
class
although
type
ii
ifn
ifng
also
welldescrib
antivir
properti
ifn
induc
uniqu
partial
overlap
set
isg
addit
isg
directli
induc
viral
infect
absenc
ifn
product
lead
isg
induct
multipl
mechan
intersect
often
selfreinforc
first
isg
discov
year
ago
past
decad
seen
genomescal
catalog
molecul
depend
cell
type
ifn
dose
time
treatment
microarray
studi
identifi
isg
gene
typic
mani
cell
type
insight
effector
function
isgencod
protein
howev
limit
primarili
hand
molecul
includ
classic
isg
pkr
also
known
recent
effector
zap
adar
tetherin
also
known
viperin
also
known
pleas
consult
wwwgenenamesorg
hugo
gene
nomenclatur
committe
hgnc
approv
design
isg
encod
protein
mani
bettercharacter
isg
particularli
ifninduc
hiv
restrict
factor
subject
recent
review
discuss
detail
summar
recent
effort
identifi
new
antivir
isg
review
emerg
theme
effector
function
mechan
microarray
data
knockout
studi
suggest
ifninduc
effector
form
divers
overlap
landscap
mice
defect
one
classic
antivir
pathway
oa
pkr
still
mount
antivir
respons
indic
sever
factor
contribut
protect
redund
probabl
reflect
central
import
isg
antivir
defens
clinic
relev
exampl
seen
patient
infect
hepat
c
viru
hcv
treat
ifnabas
drug
regimen
success
respond
treatment
isg
level
liver
low
treatment
increas
significantli
treatment
contrast
patient
fail
respond
ifn
typic
elev
pretreat
isg
level
increas
dramat
treatment
interestingli
higher
express
uniqu
isg
correl
reduct
hcv
viral
load
recent
howev
direct
evid
antivir
effect
major
isg
lack
sever
discoverybas
screen
identifi
antivir
isg
perform
depend
studi
screen
typic
design
determin
isg
effect
viru
replic
use
infecti
virus
undergo
full
life
cycl
eg
entri
uncoat
genom
replic
particl
assembl
egress
altern
replic
assay
absenc
viru
product
replicon
viral
genom
genet
design
compet
replic
unabl
produc
infecti
viru
two
smallscal
screen
isg
test
overexpress
activ
hcv
subgenom
replicon
sever
isg
includ
pkr
viperin
significantli
reduc
replicon
activ
screen
isg
dengu
west
nile
repliconcontain
viruslik
particl
yield
hit
viperin
pkr
inhibit
replicon
enzymat
activ
requir
antivir
activ
viperin
antivir
fulli
infecti
denv
ifitm
protein
propos
target
bind
entri
nucleocapsid
uncoat
result
consist
origin
report
ifitm
famili
member
antivir
factor
target
earli
life
cycl
step
sever
virus
studi
fulli
infecti
sindbi
viru
mous
isg
viperin
zap
test
antivir
activ
vitro
vivo
author
confirm
previous
report
antivir
activ
zap
identifi
viperin
antialphaviru
effector
build
need
identifi
complet
spectrum
antivir
isg
recent
report
comprehens
overexpress
screen
gene
test
antivir
activ
six
virus
hcv
yellow
fever
viru
yfv
wnv
venezuelan
equin
enceph
viru
veev
chikungunya
viru
chikv
statist
signific
reduct
viru
replic
demonstr
least
gene
half
never
character
antivir
tabl
isg
broad
activ
mani
virus
other
restrict
specif
figur
collect
gene
preferenti
inhibit
given
viru
isg
profil
uniqu
partial
overlap
profil
virus
particularli
famili
respect
hcv
littl
overlap
group
effector
inhibit
fulli
infecti
viru
compar
gene
previous
identifi
target
subgenom
replicon
differ
suggest
antivir
isg
effect
replicon
may
correl
activ
infecti
viru
interestingli
small
subset
isg
shown
enhanc
replic
virusspecif
manner
highlight
inher
complex
ifn
system
figur
grow
bodi
knowledg
isg
effector
function
begin
illumin
sever
interest
featur
global
ifn
system
one
interest
properti
isgmedi
antivir
activ
magnitud
singl
ifn
effector
inhibit
viru
replic
surprisingli
first
antivir
isg
discov
potent
eg
pkr
newer
addit
highli
activ
group
report
last
decad
zap
effector
uncov
howev
becom
clear
gradient
antivir
activ
exist
mani
act
modest
inhibitor
host
perspect
induc
divers
rang
weak
effector
may
prefer
upregul
group
extrem
potent
gene
latter
could
result
toxic
cellular
environ
experiment
observ
intermedi
phenotyp
support
hypothesi
ifn
effector
work
combin
achiev
fulli
function
antivir
state
inde
combin
two
isg
express
togeth
magnitud
antivir
activ
usual
greater
either
gene
alon
effect
observ
hcv
hepatoma
cell
hiv
cell
yfv
fibroblast
suggest
paradigm
cross
cell
type
viral
speci
convers
sindbi
viru
simultan
knockdown
innat
immun
divers
role
isg
ifn
antivir
pathway
incom
virus
sens
pattern
recognit
receptor
prr
lead
activ
interferon
regulatori
factor
irf
transcript
induct
ifn
antivir
ifn
signal
jakstat
pathway
induc
isg
product
isg
also
directli
induc
irf
ifnindepend
pathway
thin
blue
arrow
isg
function
block
viru
replic
thick
red
bar
other
abil
promot
enhanc
replic
certain
virus
green
arrow
subset
isg
compon
ifn
pathway
promot
signal
red
dot
arrow
ifn
also
induc
sever
neg
regul
target
prr
irf
jakstat
dampen
respons
thin
red
bar
interferonstimul
gene
schoggin
rice
zap
revers
ifnmedi
inhibit
viru
replic
better
individu
knockdown
zap
gene
combin
studi
potenti
defin
pathway
ifn
effector
function
much
like
epistasi
analysi
classic
genet
exampl
recent
identifi
antivir
effector
inhibit
yfv
combin
effect
stronger
result
suggest
mechan
action
base
two
independ
parallel
process
one
gene
potenti
similar
result
observ
isg
enhanc
yfv
replic
name
contrast
hpse
encod
heparan
sulfat
cleav
enzym
heparanas
potent
activ
yfv
combin
antivir
effector
level
replic
inhibit
unchang
suggest
hpse
function
upstream
cascad
antivir
function
although
antivir
mechan
heparanas
action
unknown
enzymat
activ
suggest
may
inhibit
bind
virus
util
heparan
sulfat
entri
strong
block
first
step
viral
life
cycl
would
mask
detect
inhibit
later
stage
addit
combinatori
studi
may
use
defin
isg
interact
assign
effector
function
distinct
stage
viral
life
cycl
isg
induc
vastli
differ
level
viral
infect
ifn
treatment
express
level
often
depend
time
dose
cell
type
ration
hypothesi
isg
highli
induc
infect
ifn
treatment
control
viral
replic
effect
inde
goal
infect
cell
microarray
analysi
often
identifi
highli
induc
isg
good
candid
followup
studi
principl
strategi
sound
accumul
evid
suggest
magnitud
isg
induct
alway
correl
strength
antivir
effector
function
key
exampl
famili
ifit
protein
ifit
famili
member
among
highli
induc
isg
respons
ifn
treatment
viral
infect
given
high
level
induct
surpris
overexpress
ifit
confer
modest
inhibitori
antivir
activ
recent
insight
role
ifit
famili
member
viral
infect
provid
clue
appar
discrep
use
proteom
approach
pichlmair
et
al
show
sever
ifit
famili
member
form
multiprotein
complex
sequest
viral
rna
contain
triphosph
loss
ifit
express
particularli
confer
growth
advantag
virus
gener
triphosph
rna
support
author
model
ifit
form
effector
complex
execut
ifn
antivir
activ
use
genet
approach
two
group
recent
demonstr
certain
virus
use
viral
encod
omethyltransferas
specif
evad
inhibit
ifit
protein
exampl
mutant
wnv
lack
omethyltransferas
activ
inhibit
murin
wild
type
wnv
moreov
avirul
wild
type
mice
virul
complet
restor
knockout
mice
observ
suggest
viral
evas
mechan
may
counteract
high
level
ifit
express
infect
studi
need
determin
highli
express
isg
assembl
multiprotein
effector
complex
andor
serv
target
viral
immun
evas
anoth
ifn
effector
whose
express
level
discord
antivir
activ
viperin
express
cell
infect
viperin
abl
inhibit
sever
virus
includ
hcmv
sindbi
viru
influenza
viru
dengu
viru
howev
viperin
origin
identifi
antivir
effector
highli
induc
fibroblast
infect
human
cytomegaloviru
hcmv
treat
ifn
thu
respect
hcmv
seem
paradox
viru
would
induc
high
level
antivir
protein
seo
et
al
report
hcmvencod
vmia
protein
coopt
viperin
forc
reloc
endoplasm
reticulum
mitochondria
viperin
interfer
cellular
atp
gener
modul
atp
level
result
disrupt
actin
cytoskeleton
ultim
enhanc
hcmv
infect
remark
exampl
isg
hijack
help
explain
discrep
viperin
level
appar
lack
antivir
activ
normal
infect
innat
immun
frequenc
antivir
isg
activ
six
virus
data
largescal
isg
screen
present
ref
analyz
frequenc
given
isg
shown
antivir
activ
six
virus
hcv
yfv
wnv
veev
chikv
list
gene
number
virus
gene
target
submit
wordlenet
gener
word
cloud
isg
font
size
directli
proport
preval
antivir
activ
demonstr
antivir
activ
six
virus
hundr
gene
induc
ifn
reason
assum
step
viral
life
cycl
entri
uncoat
transcript
translat
assembl
egress
could
target
inhibit
interestingli
howev
panel
eight
antivir
isg
test
effect
hcv
life
cycl
gene
impair
primari
translat
incom
genom
magnitud
translat
inhibit
correl
overal
reduct
viru
replic
later
time
point
result
suggest
least
hcv
target
earli
postentri
life
cycl
event
common
mode
isg
action
ifitm
protein
also
found
inhibit
earli
step
life
cycl
variou
virus
possibl
block
entri
viral
particl
traffick
studi
system
suggest
viru
assembl
egress
also
viabl
isg
target
exampl
isg
encod
tetherin
known
prevent
releas
virion
cell
surfac
recent
work
shown
egress
influenza
viru
also
target
isg
viperin
interact
cellular
enzym
farnesyl
diphosph
synthas
perturb
lipid
raft
result
inhibit
influenza
viru
releas
mechan
ifn
effector
uncov
like
mode
action
collect
span
major
viru
life
cycl
stage
emerg
paradigm
isgmedi
activ
context
host
process
feedback
antivir
pathway
figur
major
ifn
signal
compon
rigilik
receptor
irf
known
induc
ifn
protein
activ
pathway
among
promin
antivir
effector
numer
virus
origin
character
nearli
year
ago
studi
demonstr
exert
antivir
function
absenc
ifn
support
observ
express
human
fibroblast
result
induct
gene
major
isg
ifn
gene
therefor
appear
execut
ifnlik
antivir
program
absenc
signal
ifn
gene
induct
mechanist
ifnindepend
antivir
phenotyp
link
signal
rigilik
receptor
adapt
protein
local
specif
peroxisom
mitochondria
similar
isg
also
activ
isg
express
absenc
ifn
signal
thu
irfmedi
transcript
cascad
may
intrins
antivir
mechan
allow
rapid
isg
express
ifn
produc
recent
work
implic
isg
promot
antivir
signal
potent
zinc
antivir
protein
zap
encod
well
known
abil
inhibit
retrovirus
filovirus
alphavirus
short
isoform
protein
zap
recent
shown
select
induc
triphosphatemodifi
rna
capabl
bind
rigi
zap
rigi
interact
lead
ifn
induct
abrog
sirna
target
zap
similar
zap
modest
antivir
activ
bind
rigi
knockdown
interfer
ifn
isg
express
virusinfect
cell
viperin
also
recent
shown
promot
ifn
induct
contrast
zap
abrog
rigilik
receptor
signal
viperin
interact
tolllik
receptor
signal
mediat
ifn
product
impair
plasmacytoid
dendrit
cell
mice
lack
viperin
mice
final
pkr
recent
propos
contribut
antivir
immun
regul
ifn
mrna
integr
togeth
zap
viperin
pkr
join
grow
class
downstream
ifn
effector
whose
antivir
activ
partli
serv
reinforc
upstream
signal
pathway
recent
recogn
small
class
ifninduc
neg
regul
probabl
also
contribut
overal
pictur
provid
induc
mechan
ward
excess
inflamm
tissu
damag
figur
genomewid
microarray
analys
major
isg
messeng
rna
probabl
identifi
possibl
except
gene
uniqu
cell
type
whose
ifn
profil
yet
determin
nextgener
sequenc
platform
hold
high
promis
uncov
potenti
ifninduc
microrna
noncod
rna
may
significantli
impact
antivir
efficaci
ifn
recent
function
data
rapidli
acceler
identif
antivir
isg
character
mechan
action
respect
viral
life
cycl
host
cell
process
collect
studi
reveal
novel
concept
emerg
theme
help
accur
defin
antivir
state
ongo
work
provid
rich
platform
understand
pleiotrop
molecul
ifn
orchestr
antivir
program
furthermor
take
advantag
natur
occur
viral
inhibitor
may
effect
strategi
develop
novel
drug
treat
human
viral
diseas
